Immunic Inc
Immunic Inc (IMUX) Option Chain
As of September 21, 2026, Immunic Inc is trading at $10.83, a +1.98% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 84.6%. IV Rank is 2%.
Read more
Tracking the IMUX option chain helps you see every strike and expiry on Immunic Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Immunic Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of IMUX options activity at a glance. Use our scanner to monitor the IMUX option chain in real time and filter for the IMUX options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For IMUX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the IMUX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where IMUX stock options are being actively traded and where they are not.
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR?t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases.
Immunic, Inc. is headquartered in New York, New York.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Immunic Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen IMUX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of IMUX stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile12.70% Subdued
- Market cap (M$)148
- 52 weeks high-37.87%
- 52 weeks low114.03%
- Analyst recommendationStrong Buy
1.00 - Target price$43.09
297.88% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-12
- P/E—
- Future P/E—
- EPS (ttm)-4.81
- EPS growth next 5 years25.83%
As of September 21, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 0.03 | 1 | 0 | 0.72 | 5.83 | 5.10 | 8.00 | 5.00 | -53.83 | — | 1.00 | 0.00 | 1.00 | 0 | 0 | 99.97 |
| 5.80 | 2 | 0 | 0.77 | 3.33 | 2.70 | 5.50 | 7.50 | -30.75 | — | 1.00 | 0.00 | 1.00 | 0 | 0 | 94.20 |
| 39.57 | 27 | 8 | 0.35 | 0.83 | 0.75 | 1.60 | 10.00 | -7.66 | 0.30 | 1.20 | 0.00 | 0.75 | 0 | 132 | 60.43 |
| 77.32 | 2 | 582 | 0.30 | 0.00 | 0.10 | 0.50 | 12.50 | +15.42 | 1.55 | 2.70 | 1.67 | 0.46 | 0 | 255 | 22.68 |
| 94.27 | 115 | 5 | 0.30 | 0.00 | — | 0.30 | 15.00 | +38.50 | 3.60 | 5.00 | 4.17 | 0.13 | 0 | 54 | 5.73 |
As of September 21, 2026
Scan the full option chain in one place
Browse the full IMUX option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→